{"id":"NCT02421601","sponsor":"Seikagaku Corporation","briefTitle":"A Study of SI-6603 in Patients With Lumbar Disc Herniation","officialTitle":"A Multicenter, Open-label Study of SI 6603 in Patients With Lumbar Disc Herniation (Phase III)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2018-02","completion":"2018-02","firstPosted":"2015-04-20","resultsPosted":"2021-11-11","lastUpdate":"2023-03-23"},"enrollment":1011,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Intervertebral Disc Disease","Lumbar Disc Disease"],"interventions":[{"type":"DRUG","name":"Condoliase","otherNames":[]}],"arms":[{"label":"SI-6603","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of SI-6603(Condoliase) in patients with lumbar disc herniation.","primaryOutcome":{"measure":"Number of Participants With Treatment-Emergent Adverse Events (TEAE)","timeFrame":"26 weeks","effectByArm":[{"arm":"SI-6603","deltaMin":615,"sd":null}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":48,"countries":["United States","Germany","Romania","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":991},"commonTop":["Nuclear magnetic resonance imaging spinal abnormal","Back pain","Spinal X-ray abnormal","Pain in extremity","C-reactive protein increased"]}}